array biopharma - Robuta Search

https://www.prnewswire.com/news-releases/array-biopharma-reports-financial-results-for-the-second-quarter-of-fiscal-2019-300789518.html Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2019 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today reported results for its second quarter of fiscal 2019 and provided an update on the progress of... array biopharma financial results for the https://247wallst.com/health-and-healthcare/2015/12/16/array-biopharma-rallies-on-late-stage-win/ Array BioPharma Rallies on Late-Stage Win - 24/7 Wall St. Jan 13, 2020 - Array BioPharma reported top-line results from the ongoing Phase 3 clinical trial of binimetinib in patients with advanced NRAS-mutant melanoma, known as the... array biopharma late stage 24 7 rallies https://www.amgen.com/newsroom/press-releases/2017/07/amgen-and-array-biopharma-announce-preclinical-license-and-collaboration-agreement-in-inflammation Amgen And Array BioPharma Announce Preclinical License And Collaboration Agreement In Inflammation|... array biopharma collaboration agreement amgen announce https://www.fool.com/investing/2017/06/05/why-array-biopharma-inc-sank-135-in-may.aspx Why Array BioPharma Inc. Sank 13.5% in May | The Motley Fool Jun 5, 2017 - It was an eventful month for the clinical-stage biotech. Here's a look at the key headlines that drove the stock's performance. array biopharma 13 5 https://investingnews.com/tag/array-biopharma array biopharma | INN array biopharma inn https://www.prnewswire.com/news-releases/pfizer-to-acquire-array-biopharma-300869356.html Pfizer to Acquire Array BioPharma /PRNewswire/ -- Pfizer Inc (NYSE: PFE) and Array BioPharma Inc. (NASDAQ: ARRY) today announced that they have entered into a definitive merger agreement... pfizer acquire array biopharma https://www.fool.com/investing/2019/01/07/why-array-biopharma-deciphera-pharmaceuticals-and.aspx Why Array BioPharma, Deciphera Pharmaceuticals, and Blueprint Medicines Are Up by Double Digits... Apr 15, 2019 - Shares of all three cancer-focused companies shot higher after one of their peers got bought out for a sizable premium. https://www.biospace.com/array-biopharma-inc-and-astrazeneca-plc-announce-new-phase-2-development-plans-for-the-investigational-anti-cancer-drug-azd6244-arry-886 Array BioPharma, Inc. and AstraZeneca PLC Announce New Phase 2 Development Plans for the... https://www.biospace.com/co-founder-of-array-biopharma-inc-to-lead-new-korean-out-sourcing-chemistry-company Co-Founder Of Array BioPharma, Inc. To Lead New Korean Out-Sourcing Chemistry Company - BioSpace https://www.fool.com/investing/2019/01/09/does-eli-lillys-8-billion-splurge-make-array-bioph.aspx Does Eli Lilly's $8 Billion Splurge Make Array BioPharma a Buy Now? | The Motley Fool Apr 16, 2019 - Here's what you need to know about one of the most successful drug discovery engines in biotech. https://www.biospace.com/array-biopharma-inc-to-hold-conference-call-to-discuss-clinical-data-presentations-in-melanoma-and-colorectal-cancer-on-september-28-2015 Array BioPharma, Inc. To Hold Conference Call To Discuss Clinical Data Presentations In Melanoma... https://www.biospace.com/array-biopharma-inc-to-present-at-the-morgan-stanley-global-healthcare-conference Array BioPharma, Inc. To Present At The Morgan Stanley Global Healthcare Conference - BioSpace